Dose intensity correlate with survival in elderly patients treated with chemotherapy for advanced non-small cell lung cancer

A. Luciani, C. Bertuzzi, G. Ascione, E. Di Gennaro, S. Bozzoni, S. Zonato, D. Ferrari, P. Foa

Research output: Contribution to journalArticle

Abstract

Introduction: In elderly patients treated with chemotherapy for advanced non-small cell lung cancer (NSCLC), frequently an adequate dose intensity (DI) is difficult to be delivered. We therefore performed in this population a study to assess the delivered DI and its impact on clinical outcome. Patients and methods: Inclusion criteria were: age equal or greater than 70 years; cytological or histological diagnosis of NSCLC; stage IIIB or IV; no previous chemotherapy for advanced disease. Total relative dose intensity (RDI) was taken into account for the analysis. An RDI less than 80% was considered as suboptimal for tumor shrinkage. A survival comparison between subgroups (more or less than 80% RDI) was done. Results: 107 patients were eligible for the analysis. Mean age was 74.3 years. PS was 0-1 in 92.5% of subjects. Mean number of comorbidities was 1.86. The most frequently chemotherapy regimens used were single agent vinorelbine and single agent gemcitabine. Overall mean RDI was 68%; 36% of patients received a RDI > 80% of the originally planned one. The objective response rate (RR) was 55.2% and 33.3% respectively for patients receiving more or less than 80% of the RDI (p <0.01); a significant difference in overall survival between these two groups (p <0.0001) was also recorded. Baseline hemoglobin and body mass index (BMI) were the variables that significantly influenced the delivered RDI. Conclusions: These data suggest that in elderly patients treated with chemotherapy for advanced NSCLC an adequate dose intensity has a significant positive impact on both response rate and overall survival.

Original languageEnglish
Pages (from-to)94-96
Number of pages3
JournalLung Cancer
Volume66
Issue number1
DOIs
Publication statusPublished - Oct 2009

Keywords

  • Chemotherapy
  • Comorbidities
  • Dose intensity
  • Elderly
  • Non-small cell lung cancer
  • Polypharmacy
  • Relative dose intensity

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Fingerprint Dive into the research topics of 'Dose intensity correlate with survival in elderly patients treated with chemotherapy for advanced non-small cell lung cancer'. Together they form a unique fingerprint.

  • Cite this